Cargando…

A Model-Based Estimate of the Cost-Effectiveness Threshold in Germany

PURPOSE: Value-based pricing of new, innovative health technologies defined as pricing through economic evaluation requires the use of a basic cost-effectiveness threshold. This study presents a cost-effectiveness model that determines the cost-effectiveness threshold for life-extending new, innovat...

Descripción completa

Detalles Bibliográficos
Autor principal:	Gandjour, Afschin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2023
Materias:	Original Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10088581/ https://www.ncbi.nlm.nih.gov/pubmed/37039954 http://dx.doi.org/10.1007/s40258-023-00803-x

Ejemplares similares

Cost-effectiveness of sofosbuvir in hepatitis C genotype 1 infection in Germany: A reanalysis of published results
por: Gandjour, Afschin
Publicado: (2020)

How Many Intensive Care Beds are Justifiable for Hospital Pandemic Preparedness? A Cost-effectiveness Analysis for COVID-19 in Germany
por: Gandjour, Afschin
Publicado: (2021)

A parsimonious model to validate cost-effectiveness analyses on preventive health care
por: Gandjour, Afschin
Publicado: (2021)

Costs of patients with chronic kidney disease in Germany
por: Gandjour, Afschin, et al.
Publicado: (2020)

Was EU’s COVID-19 vaccine procurement strategy irrational? A re-analysis based on cost-effectiveness considerations
por: Gandjour, Afschin
Publicado: (2022)

Impact of the introduction of the AMNOG law on launch delays of new drugs in Germany: a comment
por: Gandjour, Afschin
Publicado: (2023)

Benefits, risks, and cost-effectiveness of COVID-19 self-tests from a consumer’s perspective
por: Gandjour, Afschin
Publicado: (2022)

The clinical and economic value of a successful shutdown during the SARS-CoV-2 pandemic in Germany
por: Gandjour, Afschin
Publicado: (2022)

Long COVID: Costs for the German economy and health care and pension system
por: Gandjour, Afschin
Publicado: (2023)

Comment on “Cost Effectiveness of Vericiguat for the Treatment of Chronic Heart Failure with Reduced Ejection Fraction Following a Worsening Heart Failure Event from a US Medicare Perspective”
por: Gandjour, Afschin
Publicado: (2022)

Predictors of negotiated prices for new drugs in Germany
por: Gandjour, Afschin, et al.
Publicado: (2020)

Value-based pricing of a COVID-19 vaccine
por: Gandjour, Afschin
Publicado: (2022)

Cost-Effectiveness of Angiotensin-Converting Enzyme Inhibitors for the Prevention of Diabetic Nephropathy in The Netherlands – A Markov Model
por: Adarkwah, Charles Christian, et al.
Publicado: (2011)

A proportional rule for setting reimbursement prices of new drugs and its mathematical consistency
por: Gandjour, Afschin
Publicado: (2020)

Optimal allocation of scarce PCR tests during the COVID-19 pandemic
por: Gandjour, Afschin
Publicado: (2023)

The price of curing cancer
por: Gandjour, Afschin
Publicado: (2021)

COVID-19 and the forgone health benefits of elective operations
por: Gandjour, Afschin
Publicado: (2022)

Pharmaceutical expenditure and gross domestic product: Evidence of simultaneous effects using a two‐step instrumental variables strategy
por: Shaikh, Mujaheed, et al.
Publicado: (2018)

Willingness to pay for new medicines: a step towards narrowing the gap between NICE and IQWiG
por: Gandjour, Afschin
Publicado: (2020)

Deterministic Sensitivity Analysis Under Ignorance
por: Gandjour, Afschin
Publicado: (2021)

Financial Incentives in the Path to Recovery from the COVID-19 Pandemic
por: Gandjour, Afschin
Publicado: (2021)

Demonstrating the value of cancer biomarkers at the population level
por: Gandjour, Afschin
Publicado: (2022)

Cost-Effectiveness Analysis of High-Efficiency Hemodiafiltration Versus Low-Flux Hemodialysis Based on the Canadian Arm of the CONTRAST Study
por: Lévesque, Renee, et al.
Publicado: (2015)

Development of the simulation-based German albuminuria screening model (S-GASM) for estimating the cost-effectiveness of albuminuria screening in Germany
por: Kairys, Paul, et al.
Publicado: (2022)

Estimating a cost-effectiveness threshold for health care decision-making in South Africa
por: Edoka, Ijeoma P, et al.
Publicado: (2020)

Estimating the cost-effectiveness of lifestyle intervention programmes to prevent diabetes based on an example from Germany: Markov modelling
por: Neumann, Anne, et al.
Publicado: (2011)

Estimation of Tinnitus-Related Socioeconomic Costs in Germany
por: Tziridis, Konstantin, et al.
Publicado: (2022)

Estimating the cost-effectiveness of a sequential pneumococcal vaccination program for adults in Germany
por: Kuchenbecker, Ulrike, et al.
Publicado: (2018)

Estimation of the cost-effective threshold of a quality-adjusted life year in China based on the value of statistical life
por: Cai, Dan, et al.
Publicado: (2021)

Country-Level Cost-Effectiveness Thresholds: Initial Estimates and the Need for Further Research
por: Woods, Beth, et al.
Publicado: (2016)

Cost-Effectiveness Threshold for Healthcare: Justification and Quantification
por: Yanovskiy, Moshe, et al.
Publicado: (2022)

Estimation of the stage-wise costs of breast cancer in Germany using a modeling approach
por: Khan, Shah Alam, et al.
Publicado: (2023)

An exploratory study to estimate cost-effectiveness threshold value for life saving treatments in western Iran
por: Moradi, Najmeh, et al.
Publicado: (2020)

Estimating the range of incremental cost-effectiveness thresholds for healthcare based on willingness to pay and GDP per capita: A systematic review
por: Iino, Haru, et al.
Publicado: (2022)

The cost-per-QALY threshold in England: Identifying structural uncertainty in the estimates
por: Zamora, Bernarda, et al.
Publicado: (2023)

Cost-effectiveness of FRAX®-based intervention thresholds for management of osteoporosis in Singaporean women
por: Chandran, M., et al.
Publicado: (2020)

The marginal benefits of healthcare spending in the Netherlands: Estimating cost‐effectiveness thresholds using a translog production function
por: Stadhouders, Niek, et al.
Publicado: (2019)

Cost-effectiveness thresholds or decision-making threshold: a novel perspective
por: Sun, Lihua, et al.
Publicado: (2023)

Low-threshold support for families with dementia in Germany
por: Hochgraeber, Iris, et al.
Publicado: (2012)

Estimation of the incidence of genital warts and the cost of illness in Germany: A cross-sectional study
por: Hillemanns, Peter, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_hmt5jfh8ebuns6pncsqhvv8t4k